Cutanea Life Sciences, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Celltrion Teams With iProgen

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

RNAi therapeutics company RXi Pharmaceuticals has appointed Robert Bitterman and Keith Brownlie to its board of directors. Mr Bitterman currently serves as president and CEO of Cutanea Life Sciences,

Osaka-based Maruho Co., Ltd has acquired Cutanea Life Sciences Inc. , a U.S. private dermatology development company based in Pennsylvania. Maruho hopes to build up its dermatology business in th